Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Edelman

Showing results (131-140 of 186) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trialPasi A Jänne, Xiaofei Wang, Mark A Socinski, et al.
Lung Cancer (Amsterdam, Netherlands)|January 7, 2014
Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancerJoe J Stephenson, John Nemunaitis, Anil A Joy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapyJohan Vansteenkiste, Primo N Lara, Thierry Le Chevalier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203Martin J Edelman, Dee Watson, Xiaofei Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 27, 2015
Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non-Small-Cell Lung CancerHelen Chow, Martin J Edelman, Giuiseppe Giaccone, et al.
Clinical Lung Cancer|November 11, 2009
Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer CongressHeather Wakelee, Bill W Loo, Kemp H Kernstine, et al.
Critical Reviews in Oncology/Hematology|April 24, 2010
A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancerRafat H Ansari, Mark A Socinski, Martin J Edelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing RadiotherapyDaniel L Adams, Diane K Adams, Jianzhong He, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 7, 2023
"Cancer's a demon": a qualitative study of fear and multilevel factors contributing to cancer treatment delaysZachary A K Frosch, Lisa M Jacobs, Caroline S O'Brien, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 2, 2008
Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancerFrank C Detterbeck, Mark A Socinski, Richard J Gralla, et al.
Pageof 19

Showing results (131-140 of 186) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trialPasi A Jänne, Xiaofei Wang, Mark A Socinski, et al.
Lung Cancer (Amsterdam, Netherlands)|January 7, 2014
Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancerJoe J Stephenson, John Nemunaitis, Anil A Joy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapyJohan Vansteenkiste, Primo N Lara, Thierry Le Chevalier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203Martin J Edelman, Dee Watson, Xiaofei Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 27, 2015
Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non-Small-Cell Lung CancerHelen Chow, Martin J Edelman, Giuiseppe Giaccone, et al.
Clinical Lung Cancer|November 11, 2009
Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer CongressHeather Wakelee, Bill W Loo, Kemp H Kernstine, et al.
Critical Reviews in Oncology/Hematology|April 24, 2010
A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancerRafat H Ansari, Mark A Socinski, Martin J Edelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing RadiotherapyDaniel L Adams, Diane K Adams, Jianzhong He, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 7, 2023
"Cancer's a demon": a qualitative study of fear and multilevel factors contributing to cancer treatment delaysZachary A K Frosch, Lisa M Jacobs, Caroline S O'Brien, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 2, 2008
Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancerFrank C Detterbeck, Mark A Socinski, Richard J Gralla, et al.
Pageof 19